Aptar Digital Health

Clinical trials sponsored by Aptar Digital Health, explained in plain language.

Now part of AptarGroup, Inc. ATR NYSE

Digital health solutions for patient support and adherence.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Completed 1

New app aims to ease cancer treatment side effects in real time

Symptom relief Completed

This pilot study tested a mobile app called Oleena designed to help head and neck cancer patients track and manage symptoms like pain and nausea during chemoradiation. 33 patients used the app while their healthcare team monitored them remotely. The goal was to see if patients an…

Sponsor: Aptar Digital Health • Aim: Symptom relief

Last updated Jun 27, 2026 07:55 UTC

Aptar Digital Health

New app aims to ease cancer treatment side effects in real time